Immune recovery following allogeneic bone marrow transplantation

A. R. Zander, J. M. Reuben, D. Johnston, L. Vellekoop, K. A. Dicke, J. C. Yau, Evan M Hersh

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

A total of 144 evaluations of cell surface markers and cellular immune functions were carried out in 57 patients undergoing allogeneic bone marrow transplantation for acute leukemia in remission and relapse and for aplastic anemia. The periods tested were pretransplant, and 1-3, 4-6, 7-12 and more than 12 months posttransplant. The determination consisted of lymphocyte counts; lymphocyte surface marking using OKT3, OKT4, and OKT8 antibodies; and determination of adherent cells, lysozymes and antibody dependent cellular cytotoxicity (ADCC) against chicken red blood cells, human red blood cells, and CEM cells. Natural killer cells were determined against K562 target cells. Lymphoblastic responses were tested after stimulation with pokeweed mitogen (PWM), concanavalin-A (Con-A), and phytohemagglutinin (PHA). We found that the progression in the leukemic state (first remission, second remission, and relapse), prior to transplantation was paralleled by a decrease in T4 lymphocytes (976/μl ± 462; 411/μl ± 222; 372/μl ± 419; P = .04). There was a lack of helper cells and an inverted T4:T8 ratio beyond one year posttransplant independent of graft-versus-host disease status. Lymphocyte functions persisted to be depressed for more than one year. We found a direct correlation of T4 helper cells and an inverse correlation of T8 suppressor cells with lymphoblastic responses to mitogens. It is hoped that the longitudinal evaluations of immune functions after allogeneic bone marrow transplantation, and the characterization of the immune defects seen may lead to better immunorestorative treatments.

Original languageEnglish (US)
Pages (from-to)177-183
Number of pages7
JournalTransplantation
Volume40
Issue number2
StatePublished - 1985
Externally publishedYes

Fingerprint

Homologous Transplantation
Bone Marrow Transplantation
CD4-Positive T-Lymphocytes
Helper-Inducer T-Lymphocytes
Erythrocytes
CD8-Positive T-Lymphocytes
Lymphocytes
Muromonab-CD3
Recurrence
Pokeweed Mitogens
CD4-CD8 Ratio
K562 Cells
Aplastic Anemia
Antibodies
Lymphocyte Count
Phytohemagglutinins
Graft vs Host Disease
Muramidase
Concanavalin A
Mitogens

ASJC Scopus subject areas

  • Transplantation
  • Immunology

Cite this

Zander, A. R., Reuben, J. M., Johnston, D., Vellekoop, L., Dicke, K. A., Yau, J. C., & Hersh, E. M. (1985). Immune recovery following allogeneic bone marrow transplantation. Transplantation, 40(2), 177-183.

Immune recovery following allogeneic bone marrow transplantation. / Zander, A. R.; Reuben, J. M.; Johnston, D.; Vellekoop, L.; Dicke, K. A.; Yau, J. C.; Hersh, Evan M.

In: Transplantation, Vol. 40, No. 2, 1985, p. 177-183.

Research output: Contribution to journalArticle

Zander, AR, Reuben, JM, Johnston, D, Vellekoop, L, Dicke, KA, Yau, JC & Hersh, EM 1985, 'Immune recovery following allogeneic bone marrow transplantation', Transplantation, vol. 40, no. 2, pp. 177-183.
Zander AR, Reuben JM, Johnston D, Vellekoop L, Dicke KA, Yau JC et al. Immune recovery following allogeneic bone marrow transplantation. Transplantation. 1985;40(2):177-183.
Zander, A. R. ; Reuben, J. M. ; Johnston, D. ; Vellekoop, L. ; Dicke, K. A. ; Yau, J. C. ; Hersh, Evan M. / Immune recovery following allogeneic bone marrow transplantation. In: Transplantation. 1985 ; Vol. 40, No. 2. pp. 177-183.
@article{a66b5280b8e84539b19391265006e388,
title = "Immune recovery following allogeneic bone marrow transplantation",
abstract = "A total of 144 evaluations of cell surface markers and cellular immune functions were carried out in 57 patients undergoing allogeneic bone marrow transplantation for acute leukemia in remission and relapse and for aplastic anemia. The periods tested were pretransplant, and 1-3, 4-6, 7-12 and more than 12 months posttransplant. The determination consisted of lymphocyte counts; lymphocyte surface marking using OKT3, OKT4, and OKT8 antibodies; and determination of adherent cells, lysozymes and antibody dependent cellular cytotoxicity (ADCC) against chicken red blood cells, human red blood cells, and CEM cells. Natural killer cells were determined against K562 target cells. Lymphoblastic responses were tested after stimulation with pokeweed mitogen (PWM), concanavalin-A (Con-A), and phytohemagglutinin (PHA). We found that the progression in the leukemic state (first remission, second remission, and relapse), prior to transplantation was paralleled by a decrease in T4 lymphocytes (976/μl ± 462; 411/μl ± 222; 372/μl ± 419; P = .04). There was a lack of helper cells and an inverted T4:T8 ratio beyond one year posttransplant independent of graft-versus-host disease status. Lymphocyte functions persisted to be depressed for more than one year. We found a direct correlation of T4 helper cells and an inverse correlation of T8 suppressor cells with lymphoblastic responses to mitogens. It is hoped that the longitudinal evaluations of immune functions after allogeneic bone marrow transplantation, and the characterization of the immune defects seen may lead to better immunorestorative treatments.",
author = "Zander, {A. R.} and Reuben, {J. M.} and D. Johnston and L. Vellekoop and Dicke, {K. A.} and Yau, {J. C.} and Hersh, {Evan M}",
year = "1985",
language = "English (US)",
volume = "40",
pages = "177--183",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Immune recovery following allogeneic bone marrow transplantation

AU - Zander, A. R.

AU - Reuben, J. M.

AU - Johnston, D.

AU - Vellekoop, L.

AU - Dicke, K. A.

AU - Yau, J. C.

AU - Hersh, Evan M

PY - 1985

Y1 - 1985

N2 - A total of 144 evaluations of cell surface markers and cellular immune functions were carried out in 57 patients undergoing allogeneic bone marrow transplantation for acute leukemia in remission and relapse and for aplastic anemia. The periods tested were pretransplant, and 1-3, 4-6, 7-12 and more than 12 months posttransplant. The determination consisted of lymphocyte counts; lymphocyte surface marking using OKT3, OKT4, and OKT8 antibodies; and determination of adherent cells, lysozymes and antibody dependent cellular cytotoxicity (ADCC) against chicken red blood cells, human red blood cells, and CEM cells. Natural killer cells were determined against K562 target cells. Lymphoblastic responses were tested after stimulation with pokeweed mitogen (PWM), concanavalin-A (Con-A), and phytohemagglutinin (PHA). We found that the progression in the leukemic state (first remission, second remission, and relapse), prior to transplantation was paralleled by a decrease in T4 lymphocytes (976/μl ± 462; 411/μl ± 222; 372/μl ± 419; P = .04). There was a lack of helper cells and an inverted T4:T8 ratio beyond one year posttransplant independent of graft-versus-host disease status. Lymphocyte functions persisted to be depressed for more than one year. We found a direct correlation of T4 helper cells and an inverse correlation of T8 suppressor cells with lymphoblastic responses to mitogens. It is hoped that the longitudinal evaluations of immune functions after allogeneic bone marrow transplantation, and the characterization of the immune defects seen may lead to better immunorestorative treatments.

AB - A total of 144 evaluations of cell surface markers and cellular immune functions were carried out in 57 patients undergoing allogeneic bone marrow transplantation for acute leukemia in remission and relapse and for aplastic anemia. The periods tested were pretransplant, and 1-3, 4-6, 7-12 and more than 12 months posttransplant. The determination consisted of lymphocyte counts; lymphocyte surface marking using OKT3, OKT4, and OKT8 antibodies; and determination of adherent cells, lysozymes and antibody dependent cellular cytotoxicity (ADCC) against chicken red blood cells, human red blood cells, and CEM cells. Natural killer cells were determined against K562 target cells. Lymphoblastic responses were tested after stimulation with pokeweed mitogen (PWM), concanavalin-A (Con-A), and phytohemagglutinin (PHA). We found that the progression in the leukemic state (first remission, second remission, and relapse), prior to transplantation was paralleled by a decrease in T4 lymphocytes (976/μl ± 462; 411/μl ± 222; 372/μl ± 419; P = .04). There was a lack of helper cells and an inverted T4:T8 ratio beyond one year posttransplant independent of graft-versus-host disease status. Lymphocyte functions persisted to be depressed for more than one year. We found a direct correlation of T4 helper cells and an inverse correlation of T8 suppressor cells with lymphoblastic responses to mitogens. It is hoped that the longitudinal evaluations of immune functions after allogeneic bone marrow transplantation, and the characterization of the immune defects seen may lead to better immunorestorative treatments.

UR - http://www.scopus.com/inward/record.url?scp=0021792466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021792466&partnerID=8YFLogxK

M3 - Article

C2 - 3895625

AN - SCOPUS:0021792466

VL - 40

SP - 177

EP - 183

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 2

ER -